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Abstract
Background: Aging and dyslipidemia are processes which can lead to deleterious consequences to renal function.
Therefore, the aim of this study was to determine the effects of both hypercholesterolemia and aging on renal
function in mice.
Methods: Male hypercholesterolemic apolipoprotein E-deficient mice (ApoE, n = 13) and age-matched C57BL/6
control mice (C57, n = 15) were studied at 2 (young) and 8 (adult) month-old. At each time point, animals were
placed in metabolic cages for 24 hours to urine volume and urinary creatinine quantification. Blood samples were
collected for serum cholesterol, urea and creatinine measurements. Glomerular filtration rate (GFR) was estimated
through creatinine clearance determination. Mesangial expansion was evaluated by Periodic Acid Schiff staining,
renal fibrosis was determined through Masson’s trichrome staining and neuronal nitric oxide synthase (nNOS)
expression in the kidney was performed by Western Blotting. To statistical analysis two-way ANOVA followed by
Fisher’s post hoc test was used.
Results: Total plasma cholesterol was increased about 5-fold in ApoE mice at both time points compared to C57
animals. At 2-month-old, GFR was already markedly reduced in ApoE compared to C57 mice (187 ± 28 vs 358 ± 92
μL/min, p < 0.05). Adult C57 (-77%) and ApoE (-50%) mice also presented a significant reduction of GFR. In
addition, serum urea was significantly increased in young ApoE animals compared to C57 mice (11 ± 1.3 vs 7 ± 0.9
mmol/L, p < 0.01). A significant mesangial expansion was observed at 2-month old ApoE mice compared to C57
mice (35 ± 0.6 vs 30 ± 0.9%, respectively, p < 0.05), which was aggravated at 8-month old animals (40 ± 3 and 35
± 3%, respectively). Tubulointersticial fibrosis was augmented at both young (17 ± 2%, p < 0.05) and adult (20 ±
1%, p < 0.05) ApoE mice compared to respective C57 age controls (8 ± 1 and 12 ± 2%, respectively). The
expression of nNOS was markedly reduced in a time-dependent manner in both strains.
Conclusions: These data show that both hypercholesterolemia and aging contribute to the loss of renal function
in mice.
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Background
Cardiovascular morbidity, which includes dyslipidemia
among the most striking risk factors, is age-related and
represents the leading cause of mortality in occidental
population [1]. Genetically predisposing to hypercholes-
terolemia usually involves alterations in lipoprotein
transport and metabolism, leading to atherosclerosis
[2-4]. Besides its relation with cardiovascular events,
hypercholesterolemia is considered a factor that contri-
butes to renal dysfunction [5] and to worsening the
state of patients with previous kidney damage [6].
Patients with dyslipidemia usually show cardiovascular
manifestations, however, few studies have focused on
the deleterious effects of hypercholesterolemia on the
progression of renal disease.
The murine model that lacks the functional gene
encoding the apolipoprotein E (ApoE), which sponta-
neously develops hypercholesterolemia and
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beings [7,8] has greatly contributed to the understanding
of these disorders. Apolipoprotein E is a constituent of
VLDL synthesized in the liver and other tissues and
serves as a high-affinity ligand for apolipoprotein E
receptors, and thus is responsible for the cellular uptake
of lipoprotein particles [3]. Although dyslipidemia and
aging are known to be risk factors for renal diseases,
there is a lack of studies concerning the effects of these
conditions together in the ApoE mouse.
I nt h ep r e s e n ts t u d yw ea i mt oe v a l u a t et h ee f f e c t so f
both hypercholesterolemia and aging on renal function
in the murine model of spontaneous atherosclerosis
compared to the normocholesterolemic C57BL/6 (C57)
mouse. Our data show that hypercholesterolemia pro-
motes early renal dysfunction in mice and aging contri-
butes to the worsening of this condition. The
mechanisms underlying this dysfunction may include
mesangial expansion, increased renal fibrosis and
reduced expression of neuronal isoform of nitric oxide
synthase (nNOS).
Results
Table 1 summarizes the results of metabolic parameters
and serum cholesterol levels in ApoE and age-matched
C57 mice. Body weight, chow and water intake and
urine production were similar in young ApoE and C57
mice. In adult mice it was observed a significant
decrease in chow intake and a significant increase in
body weight in both ApoE and C57 groups. Water
intake and urine production did not change over the
course of aging in both groups. As expected, both young
(2-month-old) and adult (8-month-old) ApoE mice pre-
sented an augmentation about 5-fold in serum choles-
terol levels when compared with age-matched C57.
The effects of age and hypercholesterolemia on renal
function were evaluated through creatinine clearance
and serum urea concentration (Figure 1). Young ApoE
mice already showed a substantial loss of renal func-
tion as indicated by the reduced creatinine clearance
compared to age-matched C57 animals (187 ± 28 vs
358 ± 92 μL/min, p < 0.05). In adult mice, creatinine
clearance was decreased by about 77% in C57 (81 ± 14
μL/min, p < 0.05) and 50% in ApoE mice (93 ± 18 μL/
min, p < 0.05) (Figure 1A). Impaired renal function in
young ApoE mice was also indicated by a significant
increase in serum urea compared to age-matched C57
Table 1 Metabolic parameters and plasma cholesterol in young (2-month-old) and adult (8-month-old) C57 and ApoE
mice.
Parameters Young Adult
C57 (7) ApoE (6) C57 (8) ApoE (6)
Body Weight (g) 25.6 ± 0.4 24.8 ± 1.0 29.1 ± 1.2
†† 28.1 ± 0.8
†
Chow Intake (g/24 h) 3.7 ± 0.4 4.0 ± 0.2 2.2 ± 0.2
†† 2.8 ± 0.3
††
Water Intake (mL/24 h) 8.2 ± 1.6 7.6 ± 0.8 6.3 ± 0.9 5.4 ± 0.6
Urine Production (mL/24 h) 2.7 ± 0.3 2.6 ± 0.4 2.2 ± 0.4 1.7 ± 0.2
Serum Cholesterol (mmol/L) 2.4 ± 0.1 15.8 ± 2.4** 3.0 ± 0.3 16.5 ± 2.0**
Values indicate means ± SEM of the number of animals in parentheses.
**p < 0.01 vs C57;
†p < 0.05 and
††p < 0.01 vs 2-month-old (2-way ANOVA).
Figure 1 Renal functional parameters in young and adult C57
and ApoE mice. Creatinine clearance (A) and serum urea (B) were
used to determine the renal function in young (2-month-old) and
adult (8-month-old) C57BL/6 (C57) and apolipoprotein E-deficient
(ApoE) mice. Values indicate means ± SEM of the number of
animals in parentheses. *p < 0.05 and **p < 0.01 vs C57 and
†p<
0.05 vs 2-month-old (2-way ANOVA).
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this condition was not exacerbated in adult animals
(Figure 1B).
The evaluation of glomerular tuft and Bowman’sc a p -
sule areas and glomeruli number showed that these
parameters were not affected by hypercholesterolemia or
aging process (data not shown).
Changes in mesangial matrix and tubulointersticial
fibrosis indicated by the percentage of glomerular
staining with periodic acid-Schiff (A) and Masson’st r i -
chrome (B) are shown in Figure 2. Mesangial expan-
sion was observed in young ApoE mice (35 ± 0.6%, p
< 0.05) compared to age-matched C57 animals (30 ±
0.9%). Aging process aggravated this condition in both
adult strains (40 ± 3% and 35 ± 3%, p < 0.05, respec-
tively). Also, increased collagen deposition was
observed in young ApoE mice (16.7 ± 2.3%, p < 0.01)
compared with 2-month-old C57 (7.6 ± 1.0%). Aging
process did not exacerbate tubulointersicial fibrosis
(11.6 ± 1.3 and 20.5 ± 1.3%, respectively). Typical
photomicrografies of mesangial expansion and
increased collagen deposition are demonstrated in Fig-
ure 2C.
Figure 3 shows that hypercholesterolemia of young
ApoE mice did not affected the renal nNOS expression
compared with age-matched C57 animals (0.24 ± 0.02
and 0.24 ± 0.02 o.d.). On the other hand, in adult ani-
mals this parameter was reduced in about 50% in both
Figure 2 Histological evaluation in kidneys of young and adult C57 and ApoE mice. A: the mesangial expansion was evaluated through
the percentage of periodic acid-Schiff staining (PAS) in the glomerulus and B: tubulointersticial fibrosis was evaluated by the percentage of
Masson’s Trichrome staining in the tubular area in young (2-month-old) and adult (8-month-old) C57BL/6 (C57) and apolipoprotein E-deficient
(ApoE) mice. C. Typical photomicrograhies showing the increase in mesangial matrix (upper panel, 40 × magnification) and collagen deposition
(lower panel, 20 × magnification) in ApoE mice. Values indicate means ± SEM of the number of animals in parentheses. *p < 0.05 and **p <
0.01 vs C57 and
†p < 0.05 vs 2-month-old (2-way ANOVA).
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respectively).
Discussion
The present study shows that the hypercholesterolemic
ApoE mouse is characterized by an early impairment of
renal function when compared with normocholesterolemic
C57 animal. The aging process aggravated this condition
in ApoE mice and promoted a significant loss of renal
function in C57 animals.
The importance of studying a murine model that lacks
the functional gene encoding the apolipoprotein E is
that it develops spontaneous hypercholesterolemia and
atherosclerotic lesions similar to those found in human
beings [7,8]. In the present study, young ApoE mice
showed significant higher levels of total plasma choles-
terol when fed normal chow, in agreement with previous
studies [9,10], although they do not show established
atherosclerotic lesions [3]. As previously reported by
others [3], hypercholesterolemia was not aggravated in
a d u l ta n i m a l s .W ea l s oo b s e r v e dar e d u c e dc h o wi n t a k e
and increased body weight in both adult C57 and ApoE
mice, which are expected metabolic changes in rodents
[11,12].
It has already been reported that hypercholesterolemia
leads to reduced renal blood flow and increased renal
vascular resistance [13], which are factors directly related
with the impairment of renal function. However, the glo-
merular filtration rate, which is considered the best para-
meter of renal function [14], it has been poorly evaluated
in the murine model of spontaneous hypercholesterole-
mia. In the present study, the glomerular filtration rate
(GFR) was estimated by the creatinine clearance method.
The main finding of our study is that GFR was markedly
impaired in the ApoE mice already at 2-month-old. This
finding corroborates the idea that renal damage pro-
moted by hypercholesterolemia could occurs indepen-
dently of renal artery stenosis [15], since young animals
do not show atherosclerotic plaques yet [16,17].
Although no changes in glomerular tuft area were
found, in agreement with no differences in glomerular
volume in ApoE mice [18], renal histology analysis
showed a marked mesangial expansion in young ApoE
mouse, which could be favored by the increased leuko-
cyte migration through glomerular capillaries [19] in
response to increased expression of adhesion molecules
caused by oxidized cholesterol [20] and thus contribut-
ing to the loss of renal function. A plausible explanation
for the effects of mesangial cells on the filtration rate is
that they present contractile properties in response to
endogenous vasoactive agents [21]. The mesangial
expansion also contributes to the extracellular matrix
expansion, which in turn could affect the filtration rate
by reducing the glomerular permeability, as indicated by
other studies [21]. However, we cannot rule out the par-
ticipation of other hypercholesterolemia-induced factors
contributing to the renal dysfunction, including reduced
nitric oxide bioavailability, exacerbation of the renin-
angiotensin system and increased oxidative stress
[15,22,23]. In accordance with this data, we observed
marked renal fibrosis in young hypercholesterolemic
animals. Increase in kidney collagen deposition is usual
pathologic observation in a variety of many renal dis-
eases, suggesting a final common pathway in progressive
renal injury [24]. Dyslipidemia can cause renal fibrosis
d u et oi n c r e a s ei ne x t r a c e l l ular matrix deposition and
reduced matrix degradation [25]. The increase in col-
lagen synthesis and activation of pro-inflammatory path-
ways by oxidized low density lipoprotein (LDL) could be
responsible for increased matrix deposition. It has
already been shown that renal tubular cells can express
scavenger receptors, which are responsible for oxidized
LDL uptake, acting as a bridge between hyperlipidemia,
oxidative stress and renal fibrosis [26].
Once the rising number and proportion of aged indi-
viduals is a global demographic trend [27], the use of
advanced age kidney donors appears as an alternative to
reduce the number of patients in the waiting list for a
transplant, but the implications of this procedure are
not well established. The aging process is known to
cause kidney dysfunction, as has been observed in
human beings [14] and experimental animals [28,29],
but not yet reported in hypercholesterolemic ApoE
mouse. Our data show that the impairment of renal
function was worsened in 8-month-old ApoE mice and
onset in age-matched C57 control animals. This result
indicates that aging is an important and independent
risk factor for the renal disease. This is corroborated by
Figure 3 Effects of hypercholesterolemia and aging on renal
nNOS expression. Renal nNOS expression was assessed by Western
Blotting in young (2-month-old) and adult (8-month-old) C57BL/6
(C57) and apolipoprotein E-deficient (ApoE) mice. Values indicate
means ± SEM of the number of animals in parentheses. o.d.: optical
density
††p < 0.01 vs 2-month-old animals (2-way ANOVA).
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in the aging process is associated with a previous renal
vasoconstriction, which leads to a reduced renal blood
flow and consequently decrease in glomerular filtration
rate [30,31]. There are also indications that temporal
renal damage is accompanied by an increase in oxidative
stress and consequently reduced bioavailability of vaso-
dilator substances [32], which could explain, at least in
part, our findings.
Increased uremia is a hallmark of renal failure [33].
Our data show an increased uremia in ApoE mice
without additive effect of aging, in agreement with
others [34]. Surprisingly, even though C57 mice pre-
sented a time-dependent reduction in glomerular filtra-
tion rate, this condition was not accompanied by an
increase in uremia. A possible explanation for this
finding could be a temporal reduction in the expres-
sion of urea transporters in the kidney [35]. This
change could reduce the urea reabsorption, with con-
sequent increased excretion of urea in the urine, which
could not be true for the ApoE mouse that already
present high uremia at young age.
T h er o l eo fn i t r i co x i d e( N O )i nt h ed e v e l o p m e n to f
renal dysfunction due to aging cannot be ruled out, since
this vasodilator agent plays an important role in glomeru-
lar hemodynamic [36]. Aging process promoted a reduc-
tion in nNOS expression in both mice strains. It has
already been reported that reduced nNOS expression and
NO production are directed related to renal injury in a
time-dependent manner in Sprague-Dawley rats [37]. In
addition, NO is also known as an anti-growth agent that
can inhibit mesangial cell proliferation and therefore
extracellular matrix production [38]. This could be
related to both age-dependent mesangial expansion and
reduction in glomerular filtration rate, as observed in
adult C57 and ApoE animals in the present study.
Conclusion
Considering that the general health of the donor and the
functional renal reserve should determine the upper age
limit for an ideal kidney donor [39], this study empha-
sizes the importance of treating dyslipidemic patients at
an early phase, to avoid the detrimental effects of high
cholesterol levels on renal physiology. It seems that,
even in the absence of established atherosclerotic pla-
ques, hypercholesterolemia can have deleterious effects
on renal function, probably due to mesangial expansion
and tubulointersticial fibrosis, as observed in young
animals.
Methods
Animals
Experiments were performed using male young (2-month-
old) and adult (8-month-old) Apolipoprotein E-deficient
mice (ApoE; n = 13) and age-matched wild-types C57BL/6
(C57; n = 15). Animals were obtained from the breeding
facility of the Transgenes and Cardiovascular Control
Laboratory at the Federal University of Espirito Santo.
Mice were fed a regular mouse chow (Labina
®) and water
ad libitum, housed in individual cages, in a temperature
(22°C) and humidity (50%) controlled room, under a 12
hours dark/light cycle. All experimental procedures were
done in accordance with the National Institute of Health
(NIH) Guide for the Care and Use of Laboratory Animals
and the protocols were previously approved by the Institu-
tional Ethics Committee for Use of Animals (CEUA, Pro-
tocol 003/2009).
Metabolic and Biochemical Parameters
Young and adult mice were housed individually in meta-
bolic cages to 24-hour urine volume determination and
measurements of chow and water intake. After that, ani-
mals were euthanized with an overdose of thiopental
(Cristalia, Sao Paulo, Brazil, 200 mg/kg, i.p.) and had
their blood collected for creatinine, cholesterol and urea
measurements. Tissues were perfused with cold phos-
phate-buffered saline (PBS, pH 7.4, 0.1 M) through the
l e f tv e n t r i c l ea n do n ek i d n e yw a sr e m o v e df o rW e s t e r n
Blot analysis. The remaining kidney was fixed in paraf-
ormaldehyde 4% in PBS to histological evaluation.
Serum cholesterol, urea and creatinine and urine crea-
tinine were measured using colorimetric kits (Bioclin
®,
Belo Horizonte, Brazil). Creatinine clearance was calcu-
lated using plasma and urine creatinine concentrations
and urine flow through the standardized formula.
Kidney Histology
After perfusion, kidneys were fixed with 4% paraformal-
dehyde in PBS and processed for morphometric and his-
tological analyses. Samples were dehydrated with
increased alcohol concentrations and mounted in paraf-
fin blocks. After that, kidneys were sliced in a micro-
tome (AO-820, American Optical, New York, USA) in
10 μm-thick sections, stained with hematoxylin-eosin
and analyzed at a 40 × magnification. Images were cap-
tured with a color video camera (VKC150, Hitachi,
Tokyo, Japan) connected to a microscope (AX70, Olym-
pus, Center Valley, PA, USA). All morphometric and
histological analysis were performed in a single-blind
manner.
The total number of glomeruli was obtained by count-
ing all glomeruli in 10 sections separated from each
other for about 200 μm to avoid counting the same glo-
merulus twice. The mean glomerular tuft area and Bow-
man’s capsule area of each kidney were obtained by
calculating the mean value of 100 glomeruli individual
areas measured using the Image J program (1.33u, Pub-
lic Domain).
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evaluate the presence of mesangial expansion and Mas-
son’s Trichrome staining was used to tubulointersticial
fibrosis quantification. A total of 30 glomeruli were used
to calculate the percentage of stained area of each kid-
ney using the Image J program.
nNOS Expression
Expression of neuronal isoform of the enzyme nitric
oxide synthase (nNOS) was performed by Western Blot,
as previously described [40]. Briefly, after perfusion, kid-
neys were homogenized with a protease inhibitor cock-
tail (Product #P2714, Sigma Aldrich, St Louis, USA) and
centrifuged at 11,000 rpm for 20 minutes at 4°C. The
supernatant was collected and protein concentration
was determined by Bradford method [41]. Protein sam-
ples were subjected to electrophoresis in polyacrylamide
gel with sodium dodecyl-sulphate (SDS-PAGE) and elec-
troblotting into a nitrocellulose membrane, which was
then blocked with 10% skimmed milk in 0.1% PBS with
Tween-20, for 60 minutes at room temperature. After
that, membranes were incubated with a polyclonal anti-
body for the nNOS (Santa Cruz Biotechnology, St Cruz,
USA) at 1:250 dilution overnight at 4°C, following by
incubation with horseradish peroxidase-labeled second-
ary anti-rabbit antibody (GE Healthcare, Product
#RPN2108, Buckinghamshire, UK) at 1:3000 dilution.
Bands were detected by enhanced chemiluminescence in
x-ray film, and band intensity was measured by densito-
metry using the Image J program (1.33u, Public
Domain). Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) expression was used as a housekeeping
control.
Statistical analysis
Data are presented as mean ± SEM. Statistical analysis
was performed using 2-way ANOVA, followed by the
Fisher’s post hoc test. The significance level was set at p
< 0.05.
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